Completed A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. NCT00428220 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more Locations Emory University, Winship Cancer Institute — Atlanta, Georgia, United States Investigational Drug Service — Atlanta, Georgia, United States The Emory Clinic — Atlanta, Georgia, United States Loyola University Medical Center — Maywood, Illinois, United States View all 113 locations View more locations Show fewer locations Loading locations... View Trial Details
